FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1051954375> ?p ?o ?g. }

• W1051954375 endingPage "439" @default.
• W1051954375 startingPage "439" @default.
• W1051954375 abstract "Treatment of chronic wounds is a difficult problem of contemporary surgery. An opportunity of curing these wounds by means of cytokines, such as interleukin-1 (IL-1), is an issue of great interest. A clinical trial of IL-1β was performed in the patients with chronic wounds of different origin. Recombinant human IL-1β was applied in six ointment compositions containing active drug (0.05 to 5000 ng/ml) using a hydrophobic vehicle. The preparations were used to treat non-healing wounds and trophic ulcers in patients with diseases of lower extremities complicated by venous insufficiency or diabetes type I and II. Clinical examinations, wound area measurements and cytological analysis of wound smears were performed before starting the treatment and in the course of therapy. Clinical results for the wound lesions (2nd and 3rd phases) have demonstrated high efficacy of ointments containing IL-1β at 0.5 to 5000 ng/ml. The most efficient concentration was determined as 50 ng IL-1β in 1 ml of ointment. IL-1β treatment caused clinical improvement of wound healing in 90% of the patients, including those with diabetes. IL-1β application during 2nd and 3rd phases of wound process showed good correlations with cytological changes in wound cell smears. When using IL-1β-containing ointments, the terms of granulation and epithelisation terms were reduced, along with 1.5-fold increase in average healing rates, as compared to conventional treatment with Solcoseril and Vulnusan. Mechanisms of IL-1β action were similar for the patients with wounds of different origin. Application of IL-1β-containing requires daily changes of wound dressings with the ointment. What to complications, local allergic reactions were detected only in 1.9% of cases. To summarize, the results of our study provide an evidence that IL-1β-containing ointment is a useful drug for effective treatment of non-healing wounds and trophic ulcers in patients. (Med. Immunol., vol. 10, N 4-5, pp 439-448) ." @default.
• W1051954375 created "2016-06-24" @default.
• W1051954375 creator A5031437811 @default.
• W1051954375 creator A5071831808 @default.
• W1051954375 creator A5075490188 @default.
• W1051954375 creator A5075697004 @default.
• W1051954375 creator A5081858289 @default.
• W1051954375 date "2014-07-17" @default.
• W1051954375 modified "2023-10-15" @default.
• W1051954375 title "INTERLEUKIN-1β APPLICATION FOR LOCAL TREATMENT OF PURULENT AND NECROTIC LESIONS OF LOWER EXTREMITIES" @default.
• W1051954375 doi "https://doi.org/10.15789/1563-0625-2008-4-5-439-448" @default.
• W1051954375 hasPublicationYear "2014" @default.
• W1051954375 type Work @default.
• W1051954375 sameAs 1051954375 @default.
• W1051954375 citedByCount "2" @default.
• W1051954375 countsByYear W10519543752019 @default.
• W1051954375 crossrefType "journal-article" @default.
• W1051954375 hasAuthorship W1051954375A5031437811 @default.
• W1051954375 hasAuthorship W1051954375A5071831808 @default.
• W1051954375 hasAuthorship W1051954375A5075490188 @default.
• W1051954375 hasAuthorship W1051954375A5075697004 @default.
• W1051954375 hasAuthorship W1051954375A5081858289 @default.
• W1051954375 hasBestOaLocation W10519543751 @default.
• W1051954375 hasConcept C126322002 @default.
• W1051954375 hasConcept C134018914 @default.
• W1051954375 hasConcept C141071460 @default.
• W1051954375 hasConcept C2776055305 @default.
• W1051954375 hasConcept C2776106345 @default.
• W1051954375 hasConcept C2780269544 @default.
• W1051954375 hasConcept C535046627 @default.
• W1051954375 hasConcept C555293320 @default.
• W1051954375 hasConcept C71924100 @default.
• W1051954375 hasConceptScore W1051954375C126322002 @default.
• W1051954375 hasConceptScore W1051954375C134018914 @default.
• W1051954375 hasConceptScore W1051954375C141071460 @default.
• W1051954375 hasConceptScore W1051954375C2776055305 @default.
• W1051954375 hasConceptScore W1051954375C2776106345 @default.
• W1051954375 hasConceptScore W1051954375C2780269544 @default.
• W1051954375 hasConceptScore W1051954375C535046627 @default.
• W1051954375 hasConceptScore W1051954375C555293320 @default.
• W1051954375 hasConceptScore W1051954375C71924100 @default.
• W1051954375 hasIssue "4-5" @default.
• W1051954375 hasLocation W10519543751 @default.
• W1051954375 hasLocation W10519543752 @default.
• W1051954375 hasOpenAccess W1051954375 @default.
• W1051954375 hasPrimaryLocation W10519543751 @default.
• W1051954375 hasRelatedWork W2000117684 @default.
• W1051954375 hasRelatedWork W2047967234 @default.
• W1051954375 hasRelatedWork W2081814204 @default.
• W1051954375 hasRelatedWork W2383009242 @default.
• W1051954375 hasRelatedWork W2407611231 @default.
• W1051954375 hasRelatedWork W2414366497 @default.
• W1051954375 hasRelatedWork W2439875401 @default.
• W1051954375 hasRelatedWork W2553275926 @default.
• W1051954375 hasRelatedWork W3083896568 @default.
• W1051954375 hasRelatedWork W4294379278 @default.
• W1051954375 hasVolume "10" @default.
• W1051954375 isParatext "false" @default.
• W1051954375 isRetracted "false" @default.
• W1051954375 magId "1051954375" @default.
• W1051954375 workType "article" @default.